Company · North York, Ontario, Canada
Ferring Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 60
- 24 authorized now
- Natural health products
- 4
- 1 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 89
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| CERVIDIL | 02231047 | Marketed | |
| CORTIMENT | 02455889 | Marketed | |
| DDAVP INJ 4MCG/ML | 00873993 | Marketed | |
| DDAVP MELT | 02284995 | Marketed | |
| DDAVP MELT | 02285002 | Marketed | |
| DECAPEPTYL | 02389282 | Marketed | |
| DURATOCIN | 02496526 | Marketed | |
| ENDOMETRIN | 02334992 | Marketed | |
| FIRMAGON | 02337029 | Marketed | |
| FIRMAGON | 02337037 | Marketed | |
| MENOPUR | 02283093 | Marketed | |
| OCTOSTIM LIQ INJ. 15MCG/ML | 02024179 | Marketed | |
| PENTASA | 02099683 | Marketed | |
| PENTASA | 02153564 | Marketed | |
| PENTASA | 02153556 | Marketed | |
| PENTASA | 02153521 | Marketed | |
| PENTASA | 02399466 | Marketed | |
| PICO-SALAX | 02254794 | Marketed | |
| REBYOTA | 02555948 | Marketed | |
| REKOVELLE | 02487462 | Marketed | |
| REKOVELLE | 02487470 | Marketed | |
| REKOVELLE | 02487489 | Marketed | |
| ADSTILADRIN | 02566680 | Approved | |
| LUTREPULSE | 02046202 | Dormant | |
| BISACODYL 5MG | 02359324 | Cancelled Post Market | |
| BRAVELLE | 02268140 | Cancelled Post Market | |
| CALTINE INJ 100 UNIT/ML (1ML AMP) | 02007134 | Cancelled Post Market | |
| CALTINE INJ 100UNIT/ML (0.5ML AMP) | 01940376 | Cancelled Post Market | |
| CHOLECYSTOKININ INJ 75UNIT/VIAL | 00873985 | Cancelled Post Market | |
| DDAVP MELT | 02285010 | Cancelled Post Market | |
| DDAVP RHINYLE | 00402516 | Cancelled Post Market | |
| DDAVP SPRAY | 00836362 | Cancelled Post Market | |
| DDAVP TABLETS 0.1MG | 00824305 | Cancelled Post Market | |
| DDAVP TABLETS 0.2MG | 00824143 | Cancelled Post Market | |
| DURATOCIN | 02231593 | Cancelled Post Market | |
| FLORAZOLE ER | 02244405 | Cancelled Post Market | |
| GYNAZOLE.1 | 02248417 | Cancelled Post Market | |
| LUTREPULSE PWS 0.8MG/VIAL | 02046210 | Cancelled Post Market | |
| LYSTEDA | 02401959 | Cancelled Pre Market | |
| MINIRIN | 02238598 | Cancelled Post Market | |
| MINIRIN | 02246500 | Cancelled Post Market | |
| NOCDURNA | 02397927 | Cancelled Post Market | |
| NOCDURNA | 02431076 | Cancelled Post Market | |
| NORPROLAC | 02223740 | Cancelled Post Market | |
| NORPROLAC | 02223759 | Cancelled Post Market | |
| NORPROLAC | 02223767 | Cancelled Post Market | |
| NORPROLAC | 02223775 | Cancelled Post Market | |
| OCTOSTIM SPRAY | 02237860 | Cancelled Post Market | |
| PENTASA ENEMA 2G/100ML | 02153548 | Cancelled Post Market | |
| PENTASA EXTENDED-RELEASE TABLETS 250MG | 02099675 | Cancelled Post Market | |
| PRESSYN AR | 02246133 | Cancelled Post Market | |
| RAFTON LIQUID - FRUIT FLAVOUR | 01992473 | Cancelled Post Market | |
| RAFTON TABLETS - FRUIT FLAVOUR | 01995081 | Cancelled Post Market | |
| REKOVELLE | 02474077 | Cancelled Post Market | |
| REKOVELLE | 02474085 | Cancelled Post Market | |
| REKOVELLE | 02474093 | Cancelled Post Market | |
| REPRONEX | 02247790 | Cancelled Post Market | |
| SECRETIN INJ 75UNIT/VIAL | 00874000 | Cancelled Post Market | |
| SODIUM CHLORIDE INJECTION USP 0.9% | 02279754 | Cancelled Post Market | |
| VASOPRESSIN INJ 20UNIT/ML USP | 00693820 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| TuZen Capsules | 80019103 | Active | |
| VSL #3 | 80042116 | Discontinued | |
| B-Natal | 80011635 | Discontinued | |
| B-natal | 80011633 | Discontinued |
Notices of Compliance
Newest first.
- REKOVELLESeptember 21, 2026 · NOC 38326 · Supplement to a New Drug Submission (SNDS)
- PENTASAJune 30, 2026 · NOC 37829 · Supplement to a New Drug Submission (SNDS)
- PENTASAApril 16, 2026 · NOC 37350 · Supplement to a New Drug Submission (SNDS)
- MENOPURMarch 23, 2026 · NOC 37266 · Supplement to a New Drug Submission (SNDS)
- ADSTILADRINMarch 16, 2026 · NOC 37129 · New Drug Submission (NDS)
- ENDOMETRINFebruary 20, 2026 · NOC 36953 · Supplement to a New Drug Submission (SNDS)
- REBYOTAMarch 5, 2025 · NOC 34958 · New Drug Submission (NDS)
- DECAPEPTYLMarch 4, 2025 · NOC 34948 · Supplement to a New Drug Submission (SNDS)
- DURATOCINJuly 22, 2024 · NOC 33689 · Supplement to a New Drug Submission (SNDS)
- PENTASAJune 11, 2024 · NOC 33429 · Supplement to a New Drug Submission (SNDS)
- DECAPEPTYLNovember 30, 2023 · NOC 32224 · Supplement to a New Drug Submission (SNDS)
- REKOVELLENovember 2, 2023 · NOC 32031 · Supplement to a New Drug Submission (SNDS)
- MENOPURJuly 7, 2023 · NOC 31162 · Supplement to a New Drug Submission (SNDS)
- LUTREPULSENovember 3, 2022 · NOC 29389 · Supplement to a New Drug Submission (SNDS)
- CERVIDILAugust 16, 2022 · NOC 28768 · Supplement to a New Drug Submission (SNDS)
- PENTASAMarch 25, 2022 · NOC 27833 · Supplement to a New Drug Submission (SNDS)
- DURATOCINMarch 23, 2022 · NOC 27816 · Supplement to a New Drug Submission (SNDS)
- MENOPURJune 1, 2021 · NOC 25973 · Supplement to a New Drug Submission (SNDS)
- OCTOSTIMMarch 22, 2021 · NOC 25484 · Supplement to a New Drug Submission (SNDS)
- MENOPURMarch 10, 2021 · NOC 25422 · Supplement to a New Drug Submission (SNDS)
- DURATOCINApril 29, 2020 · NOC 23524 · Supplement to a New Drug Submission (SNDS)
- DURATOCINFebruary 24, 2020 · NOC 23249 · Supplement to a New Drug Submission (SNDS)
- REKOVELLEApril 18, 2019 · NOC 22075 · Supplement to a New Drug Submission (SNDS)
- PENTASADecember 17, 2018 · NOC 21656 · Supplement to a New Drug Submission (SNDS)
- REKOVELLEMarch 22, 2018 · NOC 20653 · New Drug Submission (NDS)
- DURATOCINFebruary 28, 2018 · NOC 20543 · Supplement to a New Drug Submission (SNDS)
- FIRMAGONDecember 15, 2016 · NOC 18775 · Supplement to a New Drug Submission (SNDS)
- DURATOCINDecember 5, 2016 · NOC 18745 · Supplement to a New Drug Submission (SNDS)
- CORTIMENTJune 20, 2016 · NOC 18194 · New Drug Submission (NDS)
- LUTREPULSEMay 20, 2016 · NOC 18114 · Supplement to a New Drug Submission (SNDS)
- FIRMAGONMarch 22, 2016 · NOC 17892 · Supplement to a New Drug Submission (SNDS)
- ENDOMETRINOctober 5, 2015 · NOC 17365 · Supplement to a New Drug Submission (SNDS)
- FIRMAGONSeptember 1, 2015 · NOC 17247 · Supplement to a New Drug Submission (SNDS)
- BRAVELLEJanuary 13, 2015 · NOC 16515 · Supplement to a New Drug Submission (SNDS)
- DURATOCINNovember 28, 2014 · NOC 16371 · Supplement to a New Drug Submission (SNDS)
- NOCDURNASeptember 4, 2014 · NOC 16103 · Supplement to a New Drug Submission (SNDS)
- OCTOSTIMAugust 1, 2014 · NOC 15896 · Supplement to a New Drug Submission (SNDS)
- DDAVP INJECTIONApril 23, 2014 · NOC 15538 · Supplement to a New Drug Submission (SNDS)
- PENTASA SUPPOSITORIESFebruary 24, 2014 · NOC 15315 · Supplement to a New Drug Submission (SNDS)
- MENOPURFebruary 7, 2014 · NOC 15209 · Supplement to a New Drug Submission (SNDS)
- FIRMAGONApril 5, 2013 · NOC 14270 · Supplement to a New Drug Submission (SNDS)
- LYSTEDAFebruary 13, 2013 · NOC 14080 · New Drug Submission (NDS)
- PENTASAJanuary 21, 2013 · NOC 14034 · Supplement to a New Drug Submission (SNDS)
- PENTASAJanuary 3, 2013 · NOC 13980 · Supplement to a New Drug Submission (SNDS)
- NOCDURNADecember 6, 2012 · NOC 13926 · New Drug Submission (NDS)
- DECAPEPTYLJuly 5, 2012 · NOC 13463 · New Drug Submission (NDS)
- DIVIGELDecember 1, 2011 · NOC 12822 · New Drug Submission (NDS)
- LUTREPULSEAugust 27, 2010 · NOC 11693 · Supplement to a New Drug Submission (SNDS)
- OCTOSTIM SPRAYDecember 10, 2009 · NOC 10862 · Supplement to a New Drug Submission (SNDS)
- FIRMAGONNovember 16, 2009 · NOC 10784 · New Drug Submission (NDS)
- ENDOMETRINOctober 2, 2009 · NOC 10630 · New Drug Submission (NDS)
- REPRONEXJuly 9, 2009 · NOC 10362 · Supplement to a New Drug Submission (SNDS)
- DDAVP SPRAY; DDAVP RHINYLEJune 26, 2008 · NOC 9638 · Supplement to a New Drug Submission (SNDS)
- CLINDESSEFebruary 29, 2008 · NOC 9409 · New Drug Submission (NDS)
- MENOPUROctober 16, 2007 · NOC 9085 · Supplement to a New Drug Submission (SNDS)
- MENOPURAugust 20, 2007 · NOC 8980 · Supplement to a New Drug Submission (SNDS)
- BRAVELLEAugust 17, 2007 · NOC 8976 · Supplement to a New Drug Submission (SNDS)
- PENTASAMarch 16, 2007 · NOC 8656 · Supplement to a New Drug Submission (SNDS)
- DDAVP MELT TABLETSSeptember 8, 2006 · NOC 8252 · Supplement to a New Drug Submission (SNDS)
- BRAVELLEAugust 25, 2006 · NOC 8220 · Supplement to a New Drug Submission (SNDS)
- MENOPURJuly 7, 2006 · NOC 8127 · New Drug Submission (NDS)
- MINIRINMarch 30, 2006 · NOC 7861 · Supplement to a New Drug Submission (SNDS)
- MINIRINMarch 2, 2006 · NOC 7796 · Supplement to a New Drug Submission (SNDS)
- DDAVP TABLETSNovember 21, 2005 · NOC 7619 · Supplement to a New Drug Submission (SNDS)
- REPRONEXAugust 17, 2005 · NOC 7293 · Supplement to a New Drug Submission (SNDS)
- BRAVELLEJune 3, 2005 · NOC 7073 · New Drug Submission (NDS)
- REPRONEXJuly 27, 2004 · NOC 4827 · Supplement to a New Drug Submission (SNDS)
- NORPROLACMarch 15, 2004 · NOC 153 · New Drug Submission (NDS)
- GYNAZOLE.1December 23, 2003 · NOC 120 · New Drug Submission (NDS)
- REPRONEXJuly 2, 2003 · NOC 2841 · New Drug Submission (NDS)
- MINIRINOctober 17, 2002 · NOC 414 · New Drug Submission (NDS)
- FLORAZOLE ERSeptember 21, 2001 · NOC 2411 · New Drug Submission (NDS)
- PENTASAApril 30, 2001 · NOC 1680 · Supplement to a New Drug Submission (SNDS)
- PENTASAApril 30, 2001 · NOC 1681 · Supplement to a New Drug Submission (SNDS)
- DDAVPApril 17, 2001 · NOC 2168 · Supplement to a New Drug Submission (SNDS)
- DDAVPSeptember 14, 2000 · NOC 1092 · Supplement to a New Drug Submission (SNDS)
- PENTASANovember 8, 1999 · NOC 1560 · Supplement to a New Drug Submission (SNDS)
- PENTASAFebruary 23, 1999 · NOC 1934 · New Drug Submission (NDS)
- QUINTASAFebruary 3, 1999 · NOC 1938 · Supplement to a New Drug Submission (SNDS)
- QUINTASAOctober 28, 1998 · NOC 2668 · Supplement to a New Drug Submission (SNDS)
- MINIRINAugust 17, 1998 · NOC 2819 · New Drug Submission (NDS)
- OCTOSTIM SPRAYMay 6, 1998 · NOC 2829 · Supplement to a New Drug Submission (SNDS)
- DURATOCINJune 24, 1997 · NOC 3339 · New Drug Submission (NDS)
- NIDAGELApril 22, 1997 · NOC 3952 · Supplement to a New Drug Submission (SNDS)
- CERVIDILApril 7, 1997 · NOC 3738 · New Drug Submission (NDS)
- DDAVPMarch 9, 1995 · NOC 5001 · Supplement to a New Drug Submission (SNDS)
- QUINTASAFebruary 27, 1995 · NOC 4872 · Supplement to a New Drug Submission (SNDS)
- PENTASAAugust 31, 1994 · NOC 5162 · New Drug Submission (NDS)
- NIDAGELAugust 12, 1994 · NOC 5386 · New Drug Submission (NDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Endometrin effervescent vaginal tablets; Burkholderia contaminationJune 2, 2023 · Drugs · Contamination · Type II
- Menopur: Potential for a future out of specification result during shelf lifeSeptember 28, 2022 · Drugs · Product quality · Type III
- Menopur: Out of specification (Assay)August 31, 2022 · Drugs · Product quality · Type III
- Three lots of antidiuretic DDAVP Spray recalled because of potential overdose riskJuly 16, 2020 · Drugs
- DDAVP Nasal Spray, 2.5 mL/5 mL (2020-07-14)July 14, 2020 · Drugs · Product safety · Type II
- BRAVELLE (75 IU urofollitropin for injection, purified) - Recalled lots due to Reduced Therapeutic EffectOctober 23, 2015 · Drugs · Product safety
- Bravelle (2015-10-23)October 23, 2015 · Drugs · Product safety · Type II
- ENDOMETRIN (100 mg Progesterone Effervescent Vaginal Tablets) - Voluntary Recall of Two Lots Due to a Possible Lack of Therapeutic Efficacy - For Health ProfessionalsNovember 26, 2013 · Drugs · Product safety
- In vitro fertilization product (Endometrin) recalled due to possible problems with effectivenessNovember 22, 2013 · Drugs · Product safety
- DDAVP Spray (desmopressin acetate nasal spray) and DDAVP Rhinyle (desmopressin acetate nasal solution) have been associated with an increased risk of hyponatremia - For Health ProfessionalsJuly 18, 2008 · Drugs
- Archived - DDAVP Spray (desmopressin acetate nasal spray) and DDAVP Rhinyle (desmopressin acetate nasal solution) have been associated with an increased risk of hyponatremia - For the PublicJuly 18, 2008 · Drugs